(Q39660786)

13 September 2017

1 reference

title

The biologic activity of MER-BCG in experimental systems and preliminary clinical studies (English)

1 reference

13 September 2017

2

1 reference

13 September 2017

Mikulski SM

1

1 reference

13 September 2017

1 June 1977

1 reference

13 September 2017

Cancer Treatment Reviews

1 reference

13 September 2017

4

1 reference

13 September 2017

2

1 reference

13 September 2017

103-117

1 reference

Potentiation and modulation of the immune response of guinea pigs to poorly immunogenic protein-hapten conjugates by pretreatment with the MER fraction of attenuated tubercle bacilli

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Mitogenic and adjuvant activity of a methanol extraction residue (MER) of tubercle bacilli on mouse lymphoid cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Therapeutic effect of intratumoral injection of BCG and other substances in rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Serum lysozyme as a marker of host resistance. II. Patients with malignant melanoma, hypernephroma or breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Serum lysozyme as a marker of host resistance. I. Production by macrophages resident in rat sarcomata

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Mechanism of Immunologically Specific Killing of Tumour Cells by Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Colony-forming and colony-stimulating cells in relation to prognosis in leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Effect of treatment of C57BL-6 mice with the methanol extraction residue fraction of BCG on leukemogenesis induced by the radiation leukemia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Control of Carcinogenesis: A Possible Role for the Activated Macrophage

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Letter: Macrophages v. cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Methanol extraction residue of BCG in the treatment of transplanted rat tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Accelerated Development of Transplanted Mammary Tumors in Mice Pretreated With the Methanol Extraction Residue of BCG and Prevention of Acceleration by Concomitant Specific Immunization2

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Cytokinetic studies of the effects of activated macrophages on tumor target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Cell walls of mycobacteria and related organisms; Chemistry and immunostimulant properties

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Lymphocyte reactivity in patients with carcinoma of the breast and large bowel

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Protection against guinea pig hepatomas by pretreatment with subcelluar fractions of Mycobacterium bovis (BCG).

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

BCG immunotherapy of rat tumours in athymic nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Cytodestructive mechanisms provoked by lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Macrophages in solid tumors. I. Immunologically specific effector cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

MER and Other Mycobacterial Fractions in the Immunotherapy of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Protective activity of fractions of tubercle bacilli against isologous tumours in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Studies on the heterologous immunogenicity of a methanol-insoluble fraction of attenuated tubercle bacilli (BCG). II. Protection against tumor isografts

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

Effect of treatment with the MER fraction of tubercle bacilli on hydrolytic lysosomal enzyme activity of mouse peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2877%2980008-X

7 January 2021

10.1016/S0305-7372(77)80008-X

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

329986